Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Washington for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Washington only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Washington (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Anthony Truxal (NPI 1508817594)

Field	Value
Entity Type	Individual
Organization	Anthony Truxal
Address	2245 S 19th St
City	Tacoma
State	WA
ZIP	98405
Taxonomy	Ophthalmology Physician
NPI Enumerated	May 13, 2006

Payer Source	Total Paid
Medicare	$3.7M
Medicaid	$0

Key Findings

This provider is effectively a Medicare-centric ophthalmology practice: lifetime Medicare revenue is $3.7M while there is no Medicaid billing on file. The NPI was enumerated 2006-05-13 (~20 years ago), indicating long-standing enrollment that aligns with an established, predominantly Medicare patient panel. The absence of Medicaid activity suggests payer mix and network positioning are concentrated on fee-for-service Medicare rather than dual-payer outpatient access.

Revenue is highly concentrated in intravitreal drug codes: the top 3 Medicare codes account for 82.2% of total Medicare revenue, led by J0178 at $1.6M (43.1%), J2777 at $1.3M (34.1%), and 67028 at $184.4K (5.0%). This concentration indicates that a small set of high-cost injection therapies drives the majority of the practice’s Medicare earnings, creating revenue sensitivity to utilization and reimbursement of those specific drugs.

The code mix and descriptions point to a retina-focused, injection-centric service line: J0178 (injection, aflibercept), J2777 (injection, faricimab), and multiple intravitreal and implant codes (67028, J0179, J7312) show routine administration of anti-VEGF and steroid therapies. High utilization of diagnostic imaging and retinal testing codes alongside those injections implies the practice manages chronic retinal diseases (AMD, DME) with frequent imaging and follow-up.

Several diagnostic imaging codes are used at above-typical national rates: 92134 (1.6K claims, $53.4K revenue) ranks in the 95th percentile and is described as notably above typical national volume, while 92250 (622 claims, $18K revenue) ranks in the 97th percentile and is also notably above typical volume. This pattern—frequent retinal OCT and fundus photography—supports the interpretation of active medical retinal management and monitoring, not just occasional procedural care.

On competitive standing for injected therapeutics the provider sits above the national median: J0178 ranks #383 of 3204 providers (88th percentile) and J2777 ranks #142 of 2039 providers (93rd percentile), placing the clinician in the upper tiers of national activity for those drugs. Despite those high percentile ranks, the original source labels volumes for these codes as "typical, unremarkable," which suggests the provider’s activity is substantial relative to peers but consistent with common practice patterns for retina specialists.

The practice delivers a range of therapeutic options beyond anti-VEGF agents: J0179 (brolucizumab) generated $157.7K and ranks #16 of 64 providers (76th percentile), and J7312 (dexamethasone intravitreal implant) generated $69.6K and ranks #67 of 492 providers (86th percentile). These entries indicate the provider offers alternate biologic agents and steroid implants, reflecting capability to treat patients who may require therapy beyond first-line anti-VEGF.

There are smaller-volume surgical retina procedures alongside injection services: 67042 (32 claims, $29.3K revenue) ranks #239 of 1087 providers (77th percentile) and selected retinal laser and repair codes appear in the top-25 list. This mix suggests the practice performs some operative retinal work in addition to high-frequency office-based injections and imaging, though surgical revenue represents a minor share of overall Medicare income.

Certain drug/reagent lines contribute disproportionately on a per-claim basis: J3490 (61 claims, $105.8K revenue) has a high average paid/claim of $1,734, making it a notable per-claim revenue contributor despite low claim counts. Together with concentrated revenue in a few injectable codes and no Medicaid billing on file, this pattern signals operational and reimbursement concentration risk—changes to drug pricing, utilization, or Medicare reimbursement policy for these specific codes could materially affect practice revenue.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

24 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,340	$690	$1.6M
J2777	Injection, faricimab‑svoa, 0.1 mg	43,680	$30	$1.3M
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,790	$100	$184.4K
J0179	Injection, brolucizumab-dbll, 1 mg	660	$240	$157.7K
J3490	Unclassified drugs	60	$1,730	$105.8K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	460	$150	$69.6K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	700	$100	$68.7K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,620	$30	$53.4K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	410	$120	$48.8K
J2778	Injection, ranibizumab, 0.1 mg	170	$180	$31.3K

Showing 1–10 of 24

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 24 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Washington Distribution

Anthony Truxal — 2 of 24 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Washington

Full comparison — all codes billed, vs. state median

24 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J2777	7	50	12,780	$30	$599.7K
J0178	7	90	470	$680	$597.2K
J0179	2	10	660	$240	$165.8K
J2778	24	30	510	$180	$117.1K
J2781	12	10	650	$120	$88.6K
67028	15	110	550	$90	$72.9K
J3490	35	70	70	$50	$51.2K
J7312	3	20	270	$160	$46K
67042	11	40	30	$1,190	$39.2K
67108	20	20	20	$1,180	$29.6K

Showing 1–10 of 24

Related Providers

Other providers that share a Tax Identification Number (TIN) with Anthony Truxal, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Sound Retina Ps	WA	Specialist	$0	$7.4M
Himanshu Banda	WA	Retina Specialist (Ophthalmology) Physician	$5.1M	$0
Mark Nelson	WA	Ophthalmology Physician	$4.3M	$0
Matthew Asano	CO	Ophthalmology Physician	$2M	$0
Kenneth Fung	WA	Ophthalmology Physician	$1.6M	$0
Barton Blackorby	MO	Retina Specialist (Ophthalmology) Physician	$1.1M	$0
Jay Haynie	WA	Optometrist	$394.5K	$0
Jacob Light	WA	Ophthalmology Physician	$166.8K	$230

Nearby Providers

Other providers in the same ZIP code as Anthony Truxal, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Multicare Health System	WA	General Acute Care Hospital	$0	$162.2M
Multicare Health System	WA	Children's Hospital	$0	$108.4M
Franciscan Medical Group	WA	Family Medicine Physician	$0	$92.6M
Multicare Health System	WA	Family Medicine Physician	$0	$75M
Franciscan Health System	WA	General Acute Care Hospital	$0	$44.6M
Multicare Health System	WA	Pediatrics Physician	$0	$29.4M
Western Psychological And Counseling Services LLC	WA	Clinical Psychologist	$0	$20.8M
Sound Health Medical Supply	WA	Customized Equipment (DME)	$0	$20.7M
Tra-minw P S	WA	Radiology Clinic/Center	$0	$14.5M
Advanced Lifeline Services	WA	SNF/Subacute Care Certified Respiratory Therapist	$0	$12.5M

Anthony Truxal — Billing Profile & Reimbursement Data

Sign up for Anthony Truxal — Billing Profile & Reimbursement Data policy alerts

Anthony Truxal — Billing Profile & Reimbursement Data

Sign up for Anthony Truxal — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References